234 related articles for article (PubMed ID: 27017208)
1. Melatonin, an inhibitory agent in breast cancer.
Nooshinfar E; Safaroghli-Azar A; Bashash D; Akbari ME
Breast Cancer; 2017 Jan; 24(1):42-51. PubMed ID: 27017208
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824
[TBL] [Abstract][Full Text] [Related]
3. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells.
Cos S; Martínez-Campa C; Mediavilla MD; Sánchez-Barceló EJ
J Pineal Res; 2005 Mar; 38(2):136-42. PubMed ID: 15683469
[TBL] [Abstract][Full Text] [Related]
4. The potential therapeutic effects of melatonin on breast cancer: An invasion and metastasis inhibitor.
Maroufi NF; Ashouri N; Mortezania Z; Ashoori Z; Vahedian V; Amirzadeh-Iranaq MT; Fattahi A; Kazemzadeh H; Bizzarri M; Akbarzadeh M; Nejabati HR; Faridvand Y; Rashidi MR; Nouri M
Pathol Res Pract; 2020 Oct; 216(10):153226. PubMed ID: 32987338
[TBL] [Abstract][Full Text] [Related]
5. Melatonin as a selective estrogen enzyme modulator.
Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
Curr Cancer Drug Targets; 2008 Dec; 8(8):691-702. PubMed ID: 19075592
[TBL] [Abstract][Full Text] [Related]
6. Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity.
Cos S; González A; Güezmes A; Mediavilla MD; Martínez-Campa C; Alonso-González C; Sánchez-Barceló EJ
Int J Cancer; 2006 Jan; 118(2):274-8. PubMed ID: 16080194
[TBL] [Abstract][Full Text] [Related]
7. Melatonin promotes ATO-induced apoptosis in MCF-7 cells: Proposing novel therapeutic potential for breast cancer.
Nooshinfar E; Bashash D; Safaroghli-Azar A; Bayati S; Rezaei-Tavirani M; Ghaffari SH; Akbari ME
Biomed Pharmacother; 2016 Oct; 83():456-465. PubMed ID: 27427852
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of melatonin anticancer effects.
Hill SM; Frasch T; Xiang S; Yuan L; Duplessis T; Mao L
Integr Cancer Ther; 2009 Dec; 8(4):337-46. PubMed ID: 20050373
[TBL] [Abstract][Full Text] [Related]
9. Anti-Cancer Effect of Melatonin via Downregulation of Delta-like Ligand 4 in Estrogen-Responsive Breast Cancer Cells.
Rajabi A; Saber A; Pourmahdi M; Emami A; Ravanbakhsh R; Khodavirdipour A; Khodaei M; Akbarzadeh M; Abdolahi S; Hosseinpourfeizi MA; Safaralizadeh R
Recent Pat Anticancer Drug Discov; 2020; 15(4):329-340. PubMed ID: 32990541
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer therapy based on melatonin.
Sanchez-Barcelo EJ; Mediavilla MD; Alonso-Gonzalez C; Rueda N
Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):108-16. PubMed ID: 22369716
[TBL] [Abstract][Full Text] [Related]
11. Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis.
Alonso-González C; González A; Martínez-Campa C; Menéndez-Menéndez J; Gómez-Arozamena J; García-Vidal A; Cos S
Cancer Lett; 2016 Jan; 370(1):145-52. PubMed ID: 26497762
[TBL] [Abstract][Full Text] [Related]
12. Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production.
Alvarez-García V; González A; Alonso-González C; Martínez-Campa C; Cos S
J Pineal Res; 2012 Apr; 52(3):282-90. PubMed ID: 22151118
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effects of melatonin on breast cancer].
Jiang Z; Ma F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):346-351. PubMed ID: 28364111
[TBL] [Abstract][Full Text] [Related]
14. Anti-aromatase effect of resveratrol and melatonin on hormonal positive breast cancer cells co-cultured with breast adipose fibroblasts.
Chottanapund S; Van Duursen MB; Navasumrit P; Hunsonti P; Timtavorn S; Ruchirawat M; Van den Berg M
Toxicol In Vitro; 2014 Oct; 28(7):1215-21. PubMed ID: 24929094
[TBL] [Abstract][Full Text] [Related]
15. Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women.
Blask DE; Dauchy RT; Brainard GC; Hanifin JP
Integr Cancer Ther; 2009 Dec; 8(4):347-53. PubMed ID: 20042410
[TBL] [Abstract][Full Text] [Related]
16. Melatonin as an Oncostatic Molecule Based on Its Anti-Aromatase Role in Breast Cancer.
Jin Y; Choi YJ; Heo K; Park SJ
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33406787
[TBL] [Abstract][Full Text] [Related]
17. Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells.
Gonzalez A; Cos S; Martinez-Campa C; Alonso-Gonzalez C; Sanchez-Mateos S; Mediavilla MD; Sanchez-Barcelo EJ
J Pineal Res; 2008 Aug; 45(1):86-92. PubMed ID: 18298468
[TBL] [Abstract][Full Text] [Related]
18. Melatonin-estrogen interactions in breast cancer.
Sánchez-Barceló EJ; Cos S; Mediavilla D; Martínez-Campa C; González A; Alonso-González C
J Pineal Res; 2005 May; 38(4):217-22. PubMed ID: 15813897
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of melatonin's inhibitory actions on breast cancers.
Proietti S; Cucina A; Reiter RJ; Bizzarri M
Cell Mol Life Sci; 2013 Jun; 70(12):2139-57. PubMed ID: 23007844
[TBL] [Abstract][Full Text] [Related]
20. Role of melatonin in the epigenetic regulation of breast cancer.
Korkmaz A; Sanchez-Barcelo EJ; Tan DX; Reiter RJ
Breast Cancer Res Treat; 2009 May; 115(1):13-27. PubMed ID: 18592373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
